Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Keiko Shinozawa"'
Publikováno v:
Thrombosis Update, Vol 8, Iss , Pp 100111- (2022)
Introduction: Plasma factor X (FX) levels may affect the therapeutic effects of bypass hemostatic therapy among patients with hemophilia with inhibitors. This study aimed to reproduce low and high FX level conditions in vitro and analyze changes in c
Externí odkaz:
https://doaj.org/article/58df2f9630bb48188c5d5850814c3ece
Autor:
Tomoko Yamaguchi, Keiko Shinozawa, Satoru Nagatoishi, Ayano Mitsuhashi, Masato Bingo, Hiroshi Inaba, Kagehiro Amano, Kohei Tsumoto, Ei Kinai
Publikováno v:
Thrombosis Research. 222:131-139
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8b498eb789cda43023ce6164ba01496
https://doi.org/10.1016/j.thromres.2023.01.007
https://doi.org/10.1016/j.thromres.2023.01.007
Publikováno v:
International Journal of Hematology. 116:489-499
In hemophilia A, bleeding mostly correlates with factor VIII activity (FVIII:C), although some patients show discrepancy in bleeding severity and FVIII:C. We report a novel procoagulant mechanism associated with F8 p.H118R (c.353A G) in a young Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34e4bf408b2d9bc772a5ffc94cd1572
https://doi.org/10.1007/s12185-022-03381-1
https://doi.org/10.1007/s12185-022-03381-1
Autor:
Yushi, Chikasawa, Takeshi, Hagiwara, Masato, Bingo, Kagehiro, Amano, Shigeru, Kikuchi, Ayano, Mitsuhashi, Keiko, Shinozawa, Katsuyuki, Fukutake, Ei, Kinai
Publikováno v:
International Journal of Hematology. 116:622-629
Type 3 von Willebrand disease (VWD), a rare and severe subtype, can produce inhibitors in roughly 5% to 10% of cases. We present a case of type 3 VWD with inhibitors in late pregnancy, which was successfully managed with a combination of neutralizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe90495d3a75a226de4bf25b0d4ac503
https://doi.org/10.1007/s12185-022-03372-2
https://doi.org/10.1007/s12185-022-03372-2
Autor:
Ei Kinai, Hiroshi Inaba, Takeshi Hagiwara, Yushi Chikasawa, Katsuyuki Fukutake, Kagehiro Amano, Keiko Shinozawa, Masato Bingo
Publikováno v:
Journal of Thrombosis and Haemostasis
Background Genetic characteristics and genetic carrier diagnosis in Japanese hemophilia female carriers have not been evaluated. Objectives To provide genetic information on Japanese hemophilia female carriers and demonstrate the advantages of geneti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::618af1769309a32cfd5206a733f4d106
http://europepmc.org/articles/PMC8251972
http://europepmc.org/articles/PMC8251972
Publikováno v:
Japanese Journal of Thrombosis and Hemostasis. 32:330-338
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5462dfe2bf593f6534dcad6a947c2e96
https://doi.org/10.2491/jjsth.32.330
https://doi.org/10.2491/jjsth.32.330
Autor:
Katsuyuki Fukutake, Yuichi Nagakawa, So Katayanagi, Takeshi Hagiwara, Akihiko Tsuchida, Takeshi Suda, Yu Takagi, Keiko Shinozawa, Sumito Hoshino, Kenichi Iwasaki, Kenji Katsumata, Yosuke Makuuchi, Akiyoshi Seshimo
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 53:409-417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a45ce997cd83646e61f08d6ce939805
https://doi.org/10.5833/jjgs.2019.0099
https://doi.org/10.5833/jjgs.2019.0099
Autor:
Keiji, Nogami, Masashi, Taki, Tadashi, Matsushita, Tetsuhito, Kojima, Toshiaki, Oka, Shouichi, Ohga, Kiyoshi, Kawakami, Michio, Sakai, Takashi, Suzuki, Satoshi, Higasa, Yasuo, Horikoshi, Keiko, Shinozawa, Shogo, Tamura, Koji, Yada, Masue, Imaizumi, Yoshitoshi, Ohtsuka, Fuminori, Iwasaki, Masao, Kobayashi, Junki, Takamatsu, Hideyuki, Takedani, Hisaya, Nakadate, Yoko, Matsuo, Takeshi, Matsumoto, Teruhisa, Fujii, Katsuyuki, Fukutake, Akira, Shirahata, Akira, Yoshioka, Midori, Shima
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(5)
Inhibitor-development is a serious complication in patients with haemophilia (PwH). Previous studies reported that therapeutic and genetic factors could be associated with these alloantibodies. Relevant clinical features such as genetic-background an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::619733c6262c613c5b99a8ef1c80138a
https://pubmed.ncbi.nlm.nih.gov/35689832
https://pubmed.ncbi.nlm.nih.gov/35689832
Autor:
Hiroaki Shimizu, Masahiro Mihara, Masami Murakami, Nobuhiko Kobayashi, Madoka Inoue, Keiko Shinozawa, Yoshiyuki Ogawa, Hiroshi Handa, Motoo Nagasaka, Katsuyuki Fukutake
Publikováno v:
Acta Haematologica. 143:486-490
Acquired factor V inhibitor (AFVI) results from the formation of autoantibodies to coagulation factor V (FV), and the clinical phenotype can range from asymptomatic laboratory abnormalities to life-threatening bleeds. We describe a 74-year-old man wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7135502ad38d388f2c08d795ecec25b
https://doi.org/10.1159/000502730
https://doi.org/10.1159/000502730
Autor:
Satomi Nishikawa, Keiko Shinozawa, Ei Kinai, Hiroshi Inaba, Fumie Nakazawa, Kagehiro Amano, Sho Shinohara
Publikováno v:
International journal of hematology. 115(2)
Patients with non-severe hemophilia A often show discrepancies in factor VIII (FVIII) activity. However, information on variant-specific coagulation assay characteristics in Japanese patients is limited. Pathogenic variants were classified into three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::240afc1661a5583d8343a828b86e1b87
https://pubmed.ncbi.nlm.nih.gov/34751920
https://pubmed.ncbi.nlm.nih.gov/34751920